HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William C Dougall Selected Research

Infections

7/2007Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William C Dougall Research Topics

Disease

46Neoplasms (Cancer)
01/2024 - 11/2005
19Neoplasm Metastasis (Metastasis)
01/2019 - 11/2005
14Bone Resorption
02/2014 - 02/2002
12Breast Neoplasms (Breast Cancer)
01/2024 - 04/2010
9Osteolysis
09/2015 - 02/2002
7Prostatic Neoplasms (Prostate Cancer)
08/2012 - 11/2005
5Melanoma (Melanoma, Malignant)
01/2020 - 01/2018
5Carcinogenesis
01/2016 - 11/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 03/2014
3Adenocarcinoma
10/2016 - 04/2010
2Inflammation (Inflammations)
02/2024 - 10/2020
2Multiple Myeloma
10/2018 - 02/2008
2Lung Neoplasms (Lung Cancer)
01/2018 - 10/2006
2Bone Diseases (Bone Disease)
02/2009 - 12/2007
1Sarcoma (Soft Tissue Sarcoma)
11/2023
1Fibrosarcoma
11/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023
1Lymphoma (Lymphomas)
01/2023
1Chronic Disease (Chronic Diseases)
10/2020
1Renal Cell Carcinoma (Grawitz Tumor)
12/2019
1Colonic Neoplasms (Colon Cancer)
01/2018
1Poliomyelitis (Polio)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
09/2015
1Salivary Gland Neoplasms (Salivary Gland Cancer)
01/2015
1Spinal Cord Compression
01/2014
1Spontaneous Fractures (Pathological Fracture)
01/2014
1Postmenopausal Osteoporosis
08/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2010

Drug/Important Bio-Agent (IBA)

16RANK LigandIBA
11/2018 - 11/2002
14LigandsIBA
01/2024 - 07/2003
10Proteins (Proteins, Gene)FDA Link
02/2024 - 11/2005
10Immune Checkpoint InhibitorsIBA
10/2020 - 11/2016
10DenosumabFDA Link
12/2019 - 02/2009
8Hormones (Hormone)IBA
10/2016 - 07/2008
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2014 - 01/2008
7Rank-FcIBA
03/2011 - 02/2002
6ProgesteroneFDA LinkGeneric
01/2016 - 11/2010
6OsteoprotegerinIBA
03/2014 - 01/2006
5CalciumIBA
11/2023 - 07/2008
5Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2008 - 02/2002
4Messenger RNA (mRNA)IBA
01/2019 - 01/2008
3AntibodiesIBA
01/2023 - 01/2018
3Phenobarbital (Luminal)FDA Link
01/2016 - 09/2013
3Monoclonal AntibodiesIBA
09/2015 - 02/2009
2RNA (Ribonucleic Acid)IBA
11/2023 - 01/2020
2CytokinesIBA
10/2017 - 01/2015
2Immunoglobulin G (IgG)IBA
10/2017 - 07/2007
2Biomarkers (Surrogate Marker)IBA
08/2014 - 12/2007
2Docetaxel (Taxotere)FDA Link
03/2014 - 07/2008
2Estrogen ReceptorsIBA
10/2012 - 06/2012
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
03/2011 - 01/2009
2Caspase 3 (Caspase-3)IBA
07/2008 - 01/2008
2Tartrate-Resistant Acid PhosphataseIBA
01/2006 - 02/2002
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
11/2023
1Adenosine Triphosphate (ATP)IBA
01/2023
1Adenosine (Adenocard)FDA LinkGeneric
01/2023
1Purinergic P2X7 ReceptorsIBA
01/2023
1Rituximab (Mabthera)FDA Link
01/2023
1EnzymesIBA
01/2023
1daratumumabIBA
01/2023
1src-Family KinasesIBA
10/2020
1Tyrosine (L-Tyrosine)FDA Link
10/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1AntigensIBA
01/2019
1Programmed Cell Death 1 ReceptorIBA
10/2018
1Immunoglobulins (Immunoglobulin)IBA
10/2018
1Virus ReceptorsIBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1pembrolizumabIBA
01/2018
1IpilimumabIBA
01/2018
1NivolumabIBA
01/2018
1NectinsIBA
01/2018
1Fc Receptors (Fc Receptor)IBA
10/2017
1Neutralizing AntibodiesIBA
10/2017
1Transcription Factors (Transcription Factor)IBA
10/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016
1ElementsIBA
09/2015
1Progesterone Receptors (Progesterone Receptor)IBA
02/2015
1Zoledronic Acid (Zometa)FDA Link
02/2014
1Matrix Metalloproteinases (MMPs)IBA
02/2014
1tiboloneIBA
01/2013
1Estrogens (Estrogen)FDA Link
01/2013
1TamoxifenFDA LinkGeneric
10/2012
1Cyclin D1IBA
11/2010
1Progestins (Progestagens)IBA
11/2010
1CarcinogensIBA
11/2010
1Panitumumab (Vectibix)FDA Link
06/2010
1ErbB Receptors (EGF Receptor)IBA
06/2010
1TNF-Related Apoptosis-Inducing LigandIBA
04/2010
1human TNFSF10 proteinIBA
04/2010

Therapy/Procedure

17Therapeutics
01/2023 - 11/2005
9Immunotherapy
11/2023 - 11/2016
3Drug Therapy (Chemotherapy)
10/2016 - 07/2008
1Prophylactic Mastectomy
01/2016
1Molecular Targeted Therapy
01/2015
1Radiotherapy
01/2014
1Orthopedic Procedures
01/2014
1Biological Therapy
03/2011